Helicobacter pylori: An Overview on Antimicrobials and Drug Delivery Systems for its Eradication

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|11|3|306-312

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.11, Iss.3, 2014-06, pp. : 306-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Delivery Strategies for the Treatment of Helicobacter pylori Infections

By  

Current Pharmaceutical Design, Vol. 11, Iss. 6, 2005-03 ,pp. : 775-790

Bentham Science Publishers

Access to resources Recommend Favorite

Toxic Epidermal Necrolysis Induced by a Triple-Drug Regimen for Helicobacter Pylori Eradication

By Matsukawa Y.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 301-303

Adis International

Access to resources Recommend Favorite

Polysaccharides as Bacterial Antiadhesive Agents and “Smart” Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection

By  

Current Pharmaceutical Design, Vol. 21, Iss. 33, 2015-10 ,pp. : 4888-4906

Bentham Science Publishers

Access to resources Recommend Favorite

Eradication of Helicobacter pylori: current perspectives

By Pandhi P   Malhotra Samir  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1031-1038

Informa Healthcare

Access to resources Recommend Favorite

Helicobacter pylori Eradication Regimens: Is there a Difference?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 3, 2010-09 ,pp. : 194-198

John Wiley & Sons Inc

Access to resources Recommend Favorite